Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
BMRN Transcript
BioMarin Pharmaceutical Inc. (BMRN) Q4 2025 Earnings Call Transcript
Positive2-23
The earnings call summary indicates strong financial performance with a 12% revenue increase, improved net income, and higher cash flow. Despite increased operating expenses, gross margin improved, reflecting efficient cost management. The raised revenue guidance and strong growth expectations for VOXZOGO further support a positive outlook. While regulatory and competitive risks are noted, the overall sentiment remains positive due to optimistic guidance and robust financial metrics.
BioMarin Pharmaceutical Inc. (BMRN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral1-12
BioMarin Pharmaceutical Inc. (BMRN) Presents at Jefferies London Healthcare Conference 2025 Transcript
Neutral11-18
BioMarin Pharmaceutical Inc. (BMRN) Q3 2025 Earnings Call Transcript
Unknown10-27
The earnings call summary reveals several positive elements such as increased revenue guidance and raised EPS projections. However, concerns arise from higher operating expenses, potential competition affecting VOXZOGO, and management's avoidance of specific details in the Q&A session. These mixed signals, combined with uncertainties about competition and market strategy, suggest a neutral sentiment with no clear strong positive or negative trend.
BMRN Slides
BMRN Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
